Skip to main content Help with accessibility Skip to main navigation

TOCILIZUMAB (RoActemra®) in rheumatological conditions

Last Updated: 11 April 2018

Body System: Musculoskeletal system


The Pan Mersey Area Prescribing Committee recommends the prescribing of tocilizumab infusion and subcutaneous injection  (RoActemra®) for the treatment of rheumatoid arthritis and adult-onset Still’s disease, and the infusion for juvenile idiopathic arthritis, as described.